Though little is known regarding IL-6 polymorphisms and the pathogenesis of idiopathic pulmonary fibrosis in SARS-CoV-2 infections, data tend to confirm that the IL-6 174 is associated with elevated inflammatory patterns in the outcome of SARS-CoV-2 pneumonia. Here, IL6 is linked to idiopathic pulmonary fibrosis.